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Abstract
Background: Needle core biopsy, often in conjunction with ultrasonic or stereotactic guided techniques, is frequently used to
diagnose breast carcinoma in women. Confocal scanning laser microscopy (CSLM) is a technology that provides real-time digital
images of tissues with cellular resolution. This paper reports the progress in developing techniques to rapidly screen needle core
breast biopsy and surgical specimens at the point of care. CSLM requires minimal tissue processing and has the potential to
reduce the time from excision to diagnosis. Following imaging, specimens can still be submitted for standard histopathological
preparation.
Methods: Needle core breast specimens from 49 patients were imaged at the time of biopsy. These lesions had been
characterized under the Breast Imaging Reporting And Data System (BI-RADS) as category 3, 4 or 5. The core biopsies were
imaged with the CSLM before fixation. Samples were treated with 5% citric acid and glycerin USP to enhance nuclear visibility
in the reflectance confocal images. Immediately following imaging, the specimens were fixed in buffered formalin and submitted
for histological processing and pathological diagnosis. CSLM images were then compared to the standard histology.
Results: The pathologic diagnoses by standard histology were 7 invasive ductal carcinomas, 2 invasive lobular carcinomas, 3
ductal carcinomas in-situ (CIS), 21 fibrocystic changes/proliferative conditions, 9 fibroadenomas, and 5 other/benign; two were
excluded due to imaging difficulties. Morphologic and cellular features of benign and cancerous lesions were identified in the
confocal images and were comparable to standard histologic sections of the same tissue.
Conclusion: CSLM is a technique with the potential to screen needle core biopsy specimens in real-time. The confocal images
contained sufficient information to identify stromal reactions such as fibrosis and cellular proliferations such as intra-ductal and
infiltrating carcinoma, and were comparable to standard histologic sections of the same tissue. Morphologic and cellular features
of benign and cancerous lesions were identified in the confocal images. Additional studies are needed to 1.) establish correlation
of the confocal and traditional histologic images for the various diseases of the breast; 2.) validate diagnostic use of CSLM and;
3.) further define features of borderline lesions such as well-differentiated ductal CIS vs. atypical hyperplasia.
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Background
The "Gold Standard" for diagnosis of breast disease is tis-
sue biopsy followed by histological processing and path-
ologic diagnosis. A frequently used method to perform a
breast biopsy is needle core biopsy, which is less invasive
than surgical biopsy and allows tissue to be removed from
the breast with minimal scarring and no deformity of the
breast. The procedure generally produces a specimen 1–3
mm in diameter and 0.3–2 cm long depending on the
nature of the lesion. The specimens are fixed in buffered
formalin and submitted for histological processing and
evaluation. Specimen adequacy can be assessed in a lim-
ited fashion by radiographing the specimen core biopsies
to verify removal of calcifications, if calcifications were the
finding being targeted for sampling. However, specimen
adequacy cannot accurately be confirmed at the time of
biopsy and must await histologic examination. Further, if
there are no calcifications in the targeted area, no speci-
men imaging is routinely done at the time of core biopsy.
Potentially, this delay in determining specimen adequacy
could be mitigated with the use of confocal scanning laser
microscopy (CSLM). In addition, CSLM could provide the
clinician with a preliminary screening diagnosis within
minutes and permit immediate re-biopsy at the point of
care, if necessary.
Reflectance CSLM is an optical imaging technique that
provides digital images of nuclear and cellular morphol-
ogy of tissue [1]. It utilizes optical sectioning to form an
image of a single horizontal plane either on the surface of
the sample or within the sample to a depth of 300 μm.
The image records the light backscattered from intra- and
inter-cellular constituents within the tissue. The technol-
ogy has been used non-invasively in human skin in-vivo,
producing 3–5 μm thick horizontal sections and a lateral
resolution of 0.5–1.0 μm, which compares favorably with
the typical 5 μm thick sections prepared for conventional
histology. The technique has been applied intra-opera-
tively for the assessment of parathyroid glands, as an ex-
vivo application in several studies involving Mohs micro-
graphic surgery and the use of contrast agents, and in pilot
studies of ex-vivo hepatic and pancreatic tissues [2-8].
Reflectance confocal imaging has also been applied to
imaging of breast cancer in mouse and human models [9-
11].
Confocal imaging of breast needle core biopsies for path-
ological examination prior to standard histopathology
can be accomplished with minimal processing of the tis-
sue and no tissue damage in a fashion identical to pub-
lished reports for CSLM of ex-vivo skin specimens [12].
Because the images represent the spacial variation of opti-
cal backscatter within the tissue, contrast agents such as
acetic acid or citric acid can be used to enhance the optical
contrast of the nucleus relative to the extra-cellular struc-
tures such as collagen [13]. In this study, we used CSLM to
image breast needle core biopsy specimens, representing a
range of breast conditions, during a patient's visit at a radi-
ology practice specializing in breast care, and created a
representative set of confocal images with comparative
histology.
Methods
Forty-nine patients underwent needle core biopsy
between August 2001 and January 2002 at a large, free-
standing breast diagnostic clinic (Elizabeth Wende Breast
Clinic, Rochester, NY). This study has been reviewed and
approved by an Institutional Review Board (IRB) at the
University of Rochester Medical Center, Rochester, NY.
The confocal imaging was performed at the clinic at the
time of biopsy. Based on radiologist examination, the
lesions were characterized using the Breast Imaging
Reporting And Data System (BI-RADS). Biopsied cases
were assigned as either category 4 or 5. Lesions in category
4 are defined as a suspicious abnormality, and lesions in
category 5 as highly suggestive of malignancy. One cate-
gory 3 case was also biopsied and submitted for imaging
during this study. Category 3 is defined in BI-RADS as
probably a benign finding.
The confocal microscope used in this study was the com-
mercially available VivaScope 2000 (Lucid, Inc., Roches-
ter, NY), designed specifically for imaging freshly excised
surgical tissues. Details of the optical design of the confo-
cal microscope used in this study have been published
previously [14]. The system includes a diode laser illumi-
nation at a wavelength of 830 nm, maximum illumina-
tion power of 30 mW and a 30×, 0.9 numerical aperture
water immersion objective lens. The lateral resolution
with the 30× objective lens was 1 μm, and the vertical
(axial) resolution was < 5 μm. The maximum depth of
imaging was approximately 300 μm.
Core biopsies were acquired using either a vacuum-
assisted or non vacuum-assisted biopsy devices (11-gauge
Mammotome, Ethicon Endosurgery, NJ, 14-gauge Tru-
Cut, Baxter Healthcare, CA, 14-gauge Bard, AZ). The gauge
of the needle was selected by the radiologist. The freshly
excised needle core specimen contained 2–7 (an average
of 4.1) pieces of tissue. They were radiographed to identify
the pieces that contained calcium, and the piece with the
highest density of calcium was selected for imaging. If the
specimen did not contain calcium, the piece with the least
amount of fat was selected for imaging. The remaining
pieces were immediately fixed in formalin. Specimens
were excluded from the study if they contained only one
piece of tissue so that there would be no potential risk to
standard histological processing and subsequent patho-
logical diagnosis. Samples used in this study were fixed in
formalin within 20 minutes of removal.BMC Cancer 2009, 9:265 http://www.biomedcentral.com/1471-2407/9/265
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In this study we used two contrast agents, a 5% citric acid
solution and glycerin USP. Samples treated with these
contrast agents show enhanced nuclear detail and reduced
stromal reflectance. The 5% citric acid affects the nuclear
reflectance in the same way as 5% acetic acid does, causing
compaction of the chromatin, increasing the backscat-
tered light and making the nuclei appear bright in confo-
cal images. The refractive index of glycerin matches that of
collagen, reducing its reflectance. Non-adipose stromal
areas in the core biopsy specimens treated with glycerin
typically became completely translucent and facilitated
the ability to image into the specimen.
Core specimens were submerged in a 5 ml fresh solution
of 5% citric acid by mixing 2.5 ml of 10% citric acid and
2.5 ml of 0.9% sodium chloride irrigation solution
(saline) for 30 seconds. The specimen was then removed
from the solution, placed with a drop of glycerin in a tis-
sue cassette and encapsulated with a second adhesive win-
dow that stabilized the tissue and prevented drying. The
cassette was photographed and placed on the tissue stage
of the microscope. The tissue was brought into focus, the
laser power was adjusted for optimal image quality, and a
composite mapping sequence was initiated. The compos-
ite map is a series of full field (475 × 475 μm) images in a
single, horizontal plane that are automatically captured
and "stitched" together to form a composite image that
ranged from 4 × 4 mm to 12 × 12 mm square. This mosaic
of images "cuts" an optical section into the specimen close
to its surface. Areas of interest were identified and real-
time imaging was performed in a 475 × 475 μm field. In
areas of interest, a stack of 16 images was captured within
the tissue, with each sequential image corresponding to a
3.175 μm step deeper into the tissue. The thickness of a
single 16-image stack was approximately 50.4 μm.
Sequential stacks of images were captured as long as
image quality and resolution were maintained, to a maxi-
mum depth of 300 μm. Individual full field images were
captured as needed. The complete imaging process took
10–20 minutes, although initial images were obtained in
less than five minutes. Following imaging the tissue piece
was fixed in buffered formalin along with the rest of the
specimen and submitted for standard histological
processing (Rochester General Hospital). The unaltered
confocal images were reviewed and comparable photom-
icrographs of the histology were taken.
To evaluate the influences of the contrast agents on immu-
nohistochemical staining, we undertook an IRB-approved
(University of Rochester Medical Center) compatibility
study on waste mastectomy tissue to examine the effect of
different combinations of 10% citric acid, 10% buffered
citric acid, 5% acetic acid, glycerin USP, and a saline bath
on ER/PR and HER-2/nu stains. The intent of the study
was to test the effects of citric acid and acetic acid at the
same molarity on breast tissue. The citric acid was buff-
ered with 0.803 M sodium citrate to a pH of 2.4, to match
the pH of 5% acetic acid and closely match its molarity of
0.839 M. We compared the appearance of immunohisto-
chemical stains on specimens that were treated with con-
trast agents to control specimens that were untreated.
Following treatment, all specimens were fixed in buffered
formalin, submitted for standard histologic processing
(University of Rochester Medical Center), and submitted
for ER/PR staining, and HER-2/nu staining if cancer was
suspected. Pathologists reviewed the sections and stained
tissues for artifacts and immunological staining effects
outside that typically seen.
Results
Needle core biopsy specimens were imaged from 49
patients whose breast lesions had been categorized as BI-
RADS 3, 4 or 5. The pathologic diagnoses from standard
histology were 7 invasive ductal carcinomas, 2 invasive
lobular carcinomas, 3 ductal carcinomas in-situ, 21 fibro-
cystic changes/proliferative conditions, 9 fibroadenomas,
5 other/benign; two were excluded due to imaging diffi-
culties.
Confocal images comparable to standard pathological
sections were taken from the same piece of tissue, but not
necessarily of the identical field because of differing tissue
orientation and sectioning depth. Samples treated with
5% citric acid solution and glycerin showed enhanced
nuclear detail and reduced stromal reflectance. The confo-
cal images taken from the needle core biopsy samples
showed a range of morphologic features associated with
benign and cancerous lesions when reviewed by the three
pathologists. Radiological and H&E data from 7 cases are
shown (Table 1). Representative confocal images (A) and
corresponding H&E images (B) are shown in the figures
[Figures, 1, 2, 3, 4, 5, 6 &7]. All scale bars are 50 μm in
length.
The results of the compatibility study (Table 2) indicated
that in samples of specimen 7, which was ER positive, a
solution with a pH ≤ 2.4 induced a false negative ER stain
(Figure 7B, C). In specimen 1, which was PR control pos-
itive, a solution with a pH < 2.4 induced a false negative
PR stain. Glycerin USP was not found to have any effect
on either ER/PR or HER-2/nu staining. None of the agents
induced a false positive or negative HER-2/nu stain.
Hematoxylin and eosin staining was not affected by any of
the preparations.
Discussion
The results of the breast needle core study confirm that
confocal images can be safely obtained without compro-
mising the ability to make a diagnosis by standard his-
topathologic preparation. The compatibility studyBMC Cancer 2009, 9:265 http://www.biomedcentral.com/1471-2407/9/265
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indicated that current immunohistochemical stains are
not affected by citric acid or acetic acid if the pH of the
contrast agents is buffered to ph>2.4 and the samples are
bathed in saline prior to fixation. Also, this study illus-
trates that CSLM can image features important in the dif-
ferential diagnosis of breast disease from a range of
patients that are presenting for a percutaneous needle core
biopsy. However, this study was not structured to deter-
mine the sensitivity and specificity of confocal diagnostic
criteria. The three pathologists that reviewed the confocal
images were aware of the diagnoses from the histologi-
cally prepared specimens and were able to view the case
slides while viewing the images. Overall, when viewing
the breast tissue using confocal imaging, the architectural
and cytologic features characteristic of each diagnosis
were analogous to those seen using standard histologic
processing. The diagnosis most easily made was distin-
guishing invasive carcinoma from benign tissue. The
architectural patterns of invasion characteristic of both
invasive ductal and lobular carcinoma were easily seen.
Fibrosis was distinguished without difficulty from inva-
sive carcinoma by cellularity, morphology of the nuclei,
and the relationship of the nuclei to each other. For nor-
mal breast tissue, the architecture of ducts, terminal ducts
and acini was clearly visible and benign alterations of
these structures such as cysts, apocrine metaplasia and
Table 1: Representative Cases
Radiologic 
Impression/
Technique
Patient BI-RADS 
Category
Needle Gauge 
(G)
Pieces of tissue in 
specimen
Pieces of tissue 
imaged
Pathologic diagnosis
Calcium positive/
mammogram
1 4 11 7 1 Fibrocystic changes with 
calcifications
mass/mammogram, 
ultrasound
2 4 14 4 1 Fibrocystic changes with 
calcifications
mass/sonogram 3 3 14 3 1 Fibrocystic changes with 
apocrine metaplasia
Calcium positive/
mammogram
4 4 11 5 1 Ductal carcinoma in situ
Speculated mass/
Mammogram, 
sonogram
5 4 14 3 1 Infiltrating ductal 
carcinoma
Mass/mammogram, 
ultrasound
6 5 14 2 1 Infiltrating lobular 
carcinoma
Palpable mass/
ultrasound
7 5 14 5 1 Poorly differentiated 
infiltrating ductal 
carcinoma
Fibrocystic changes Figure 1
Fibrocystic changes. CSLM (A) and H&E (B) images show the lumen of a cyst (*) lined by a layer of small, somewhat flat-
tened epithelial cells (arrows). The nuclei of stromal cells (spindle shaped fibroblasts and rounded lymphocytes) are evident 
adjacent to the cyst (arrowheads).BMC Cancer 2009, 9:265 http://www.biomedcentral.com/1471-2407/9/265
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fibroadenomas were obvious. Intraductal proliferations,
such as usual ductal hyperplasia and ductal carcinoma in
situ, showed architectural and cytologic features in confo-
cal imaging equivalent to those seen using standard his-
tology. Limitations that are typically encountered in
standard histology, such as distinguishing atypical prolif-
erations and low grade ductal carcinoma in situ, are
expected in confocal imaging as well. One challenge for
confocal imaging is viewing specimens composed pre-
dominantly of fatty tissue; however, most clinically signif-
icant lesions are not expected to be associated primarily
with fat.
There are three principal technical challenges in imaging
needle-core breast specimens with CSLM. The first is the
limited sampling of the tissue. The second is the heteroge-
neous nature of breast tissue. The third is limited reflect-
ance contrast of the epithelial tissue.
Sampling
The volume of tissue imaged precluded the ability to com-
pletely screen the specimen. Only one mosaic was taken,
and from this mosaic multiple image stacks of suspicious
regions were acquired. This was due to limitations in the
imaging speed of the system and the protocol require-
Fibrocystic changes Figure 2
Fibrocystic changes. CSLM (A) and H&E (B) images show the microanatomy of the branching terminal duct lobular unit and 
the epithelial lining of a microcyst. Fibroblasts in the surrounding stroma contain bright nuclei (arrowheads).
Apocrine metaplasia Figure 3
Apocrine metaplasia. The intensity of the nuclei in the CSLM image (A) may be attributed to better permeation of the citric 
acid solution in this partially fragmented specimen. The fine granularity of the cytoplasm corresponds to the eosinophilic gran-
ularity of apocrine cells in the H&E (B).BMC Cancer 2009, 9:265 http://www.biomedcentral.com/1471-2407/9/265
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ments to fix the tissue within 20 minutes. Because of the
limited sampling, frank cancers were often easily seen, but
localized ductal carcinoma in situ could be overlooked.
Sampling can be improved through enhancements in
hardware and software. In this study the mosaic was taken
over a square region that circumscribed the tissue, but
much of the imaged area did not contain tissue. New ver-
sions of the software application allow for the collection
of a 10 × 10 mm color macroscopic photo. From this mac-
roscopic photo, the operation can direct the collection of
imaged mosaics and stacks. Also, the tissue cassette that
held the specimens did not orient the specimen in a par-
ticular direction. Using a specifically designed carrier that
would orient the specimens lengthwise, the imaging time
could be reduced by aligning the tissue with the mechan-
ical motion. The system used in the study imaged 0.475 ×
Ductal carcinoma in situ, nuclear grade 2 Figure 4
Ductal carcinoma in situ, nuclear grade 2. (A) Lumens of the ducts are filled with neoplastic cells with nuclear atypia (*). 
The nuclei in the CSLM images, represented by the irregular oval to circular granular white structures, are crowded and abnor-
mally arranged. (B) The distinction between atypical hyperplasia and low grade ductal carcinoma in situ cannot always be made 
on the basis of the CSLM image.
Infiltrating ductal carcinoma, nuclear grade 1 with tubular features Figure 5
Infiltrating ductal carcinoma, nuclear grade 1 with tubular features. (A) The well-defined nature of the infiltrating 
groups of cells and the relatively small, uniform nuclei (arrows) is evident in both images. Sequentially captured 16-image stacks 
demonstrated central lumens in some of the groups. The lumens of the tubular-like structures are better defined in the H&E 
image (B).BMC Cancer 2009, 9:265 http://www.biomedcentral.com/1471-2407/9/265
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0.475 mm at 9 frames per second, or 2.0 mm2 per second.
A core specimen 1.5 mm in diameter and 10 mm in length
aligned in a carrier could be imaged at four depths with a
fully optimized system in less than two minutes.
Heterogeneous nature of breast tissue
The depth of imaging (less than 0.3 mm) of the confocal
microscope is a limitation for large specimens in that it
allows for examination near the surface only. This depth
limitation is related to refractive index inhomogeneity of
the tissue and the large numerical aperture (0.9) of the
imaging system. Of the three main types of tissue in the
breast, the adipose tissue limits imaging depth the most.
The refractive index of human mesenteric adipose tissue is
1.467 versus 1.41 for the surrounding collagen [15]. This
refractive difference induces large optical abberations
when attempting to image through a single layer of adi-
pose tissue. Imaging of epithelium in collagen is possible
since, as noted earlier, collagen regions of the core biopsy
were translucent after treatment with glycerin due to the
Infiltrating lobular carcinoma, nuclear grade 2 Figure 6
Infiltrating lobular carcinoma, nuclear grade 2. Small malignant cells are infiltrating the breast tissue in single file arrange-
ments (arrows) and small nests in images A and B. Nuclear pleomorphism is shown.
Poorly differentiated infiltrating ductal carcinoma, nuclear grade 3 Figure 7
Poorly differentiated infiltrating ductal carcinoma, nuclear grade 3. Although the margins of the nuclei are not 
sharply defined in CSLM (A), the arrangement of tumor cells in diffusely infiltrating nests and aggregates (*) is evident. Residual 
fat cells are seen as dark, round spaces (arrows). The H&E image (B) shows sharper definition of the nuclear features in this 
case.BMC Cancer 2009, 9:265 http://www.biomedcentral.com/1471-2407/9/265
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index matching of glycerin. The index matching reduces
both scattering and image abberations. Ducts and glands
could be seen visually as pale white structures inside the
translucent specimens. The visibility of epithelial struc-
tures is believed to be from enhanced backscatter/aceto-
whitening of the cellular tissues. Thus, epithelial regions
appeared as bright areas in the mosaic, whereas, the glyc-
erin-perfused fibrous tissue appeared dark. In areas away
from adipose tissue, epithelium could be imaged to
depths greater than 0.3 mm albeit with less resolution
than when at the surface. Epithelial proliferations could
be detected but not graded at that depth. With advances in
the design of the tissue carrier that would allow for imag-
ing on both sides of the carrier, we believe that it will be
possible to image epithelium of smaller pieces of tissue to
a combined depth of almost 1 mm.
Contrast in reflectance confocal imaging
Acetic and citric acid increases the endogenous backscatter
from the nucleus to increase the contrast of the images.
Increasing the contrast was straight forward with the nee-
dle core specimens; a 30 second immersion induced
nuclear brightening throughout the imaging depth,
although the nuclear brightness was greater near the sur-
face than deep in the tissue. This difference can be attrib-
uted to reduced optical resolution deep in the tissue and
reduced effect of the acid due to pH buffering of the tissue.
The cancerous regions often appeared brighter relative to
the normal epithelium in the surrounding tissue, most
likely due to the larger nuclei. However, the citric acid
treatment did not provide specific contrast associated with
cancer. Recent work with exogenous fluorescent dyes and
Table 2: Compatibility Study Results
Sample† Preparation* Protocol ER PR HER 2/nu Pathologic diagnosis
Normal Cancer Normal Cancer Normal Cancer
1A 1 NA + NA + NA - DCIS
1B 2 NA + NA - NA - DCIS
1C 3 NA + NA + NA - DCIS
2A 1 NA - NA - NA + DCIS
2B 4 NA - NA - NA + DCIS
2C 5 NA - NA - NA + DCIS
3A 1 + NA + NA NA NA Normal
3B 6 + NA + NA NA NA Normal
3C 5 + NA + NA NA NA Normal
5A 1 NA - NA - NA + DCIS
5B 5 NA - NA - NA + DCIS
5C 4 NA - NA - NA + DCIS
6A 1 + - + - NA - Invasive DC
6B 4 NA - NA - NA - Invasive DC
6C 5 NA - NA - NA - Invasive DC
6D 8 NA - NA - NA - Invasive DC
7A 1 + NA + NA NA NA Normal
7B 9 - NA + NA NA NA Normal
7C 10 - NA + NA NA NA Normal
7D 5 + NA + NA NA NA Normal
8A 5 + weak NA + NA NA NA Normal (atrophic)
8B 1 + weak NA + NA NA NA Normal (atrophic)
8C 1 + weak NA + NA NA NA Normal (atrophic)
9A 5 NA - NA - NA - Invasive DC
9B 1 NA - NA - NA - Invasive DC
9C 1 NA - NA - NA - Invasive DC
10A 5 + NA + NA NA NA Normal
10B 3 + NA + NA NA NA Normal
10C 11 + - + - NA - Normal and DCIS
10D 1 + - + - NA - Normal and DCIS
†While 10 cases were studied, sample 4 was excluded due to inadequate tissue handling. * Preparation Protocol: Preparation 1: Control; 
Preparation 2: Unbuffered 10% citric acid (1 min) and saline bath (5 min); Preparation 3: Buffered 10% citric acid (1 min) and glycerin (3 min) 
without saline; Preparation 4: Glycerin (3 min) without saline; Preparation 5: Buffered 10% citric acid (1 min) and glycerin (3 min) and saline bath; 
Preparation 6: Buffered 10% citric acid (1 min) without saline bath; Preparation 7: 5% Acetic acid (5 min) without saline bath; Preparation 8: 
Glycerin (3 min) with saline bath (5 min); Preparation 9: Unbuffered 10% citric acid (1 min) and glycerin (3 min) with saline bath (5 min); Preparation 
10: 5% Acetic acid (1 min) and glycerin (3 min) without saline bath; Preparation 11: Mixture of buffered 10% citric acid and 5% acetic acid (1 min) 
and glycerin (3 min) without saline bath.BMC Cancer 2009, 9:265 http://www.biomedcentral.com/1471-2407/9/265
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nano particles that attach to dysplastic or cancerous tissue
may provide enhanced cancer specific contrast [16-18].
These dyes and nano particles require more elaborate
staining protocols, including additional steps to differen-
tiate the contrast agent. Compatibility studies will need to
be carried out to ensure that they do not affect the routine
prognostic studies, such as immunohistochemistry and
FISH, used in the clinical care of breast cancer patients.
However, these agents demonstrate our ability to specifi-
cally label cancerous regions and may aid in the rapid
detection of cancer in breast specimens in the future.
Confocal scanning laser microscopy has many potential
applications in the practice of surgical pathology. Rapid
diagnoses or determinations of adequacy could be given
on core biopsy specimens, margins could be assessed by
either ex vivo tissue imaging or intraoperative consulta-
tions at the time of primary surgical excision and CSLM
could aid in the selection of sections to submit for micro-
scopic study in large primary excisions or in the evalua-
tion of re-excision specimens. These applications could
result in a decreased time to diagnosis, reduced rate of re-
excision, lower cost of pathology specimen processing,
and improved patient care.
Although the size of this study is limited, the cases imaged
represent a spectrum of breast conditions that require
biopsy as determined by radiographic examination and
patient history. We show that important morphological
features of breast conditions can be imaged using CSLM.
Our results call for further studies of percutaneously
retrieved or open surgical specimens using reflectance or
fluorescence confocal imaging with either single wave-
length systems or newer multi-wavelength devices. In
addition, we advocate the construction of a comprehen-
sive atlas to develop the diagnostic criteria necessary for
confocal screen of breast specimens.
Conclusion
Morphologic and cellular features of benign and cancer-
ous lesions were identified in the confocal images. The
images contained sufficient information to identify stro-
mal reactions such as fibrosis, and cellular proliferations
such as ductal carcinoma in situ and infiltrating carci-
noma, and were comparable to standard histologically-
prepared sections of the same tissue. Confocal images can
be enhanced by immersing the tissue in 5% citric acid
solution for 30 seconds and then immersing and viewing
it in glycerin. After confocal imaging, the tissue remains
intact and available for standard histological processing,
including the use of immunohistological stains. The
effects of citric acid and glycerin immersion on subse-
quent histologic processing are demonstrated. Tissue
treated with 5% acetic acid or 5%–10% citric acid should
be bathed in saline for 5 minutes prior to fixation, and the
pH of either acetic acid or citric acid should be buffered to
pH>2.4 to preserve receptor reactivity.
Because reflectance confocal images are visually different
from traditionally processed histological sections, an atlas
of comparative pathology is needed. To further build an
atlas, additional studies are required to develop a compre-
hensive understanding of the correlation of confocal
images to traditionally prepared slides for the various con-
ditions and diseases of the breast.
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